Company: APXT
Filing Date: 2025-10-01
Form Type: S-1/A
Source: 0001213900-25-094793
Chunk: 239

Company: Apex Treasury Corp
Filing Date: 2025-10-01
Form: S-1/A
Chunk 239
---
 of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our Class A ordinary shares held by non -affiliatesequals or exceeds $250 million as of the end of that year’s second fiscal quarter, or (2) our annual revenues equaled or exceeded $100 million during such completed fiscal year and the market value of our Class A ordinary shares held by non -affiliatesexceeds $700 million as of the end of that year’s second fiscal quarter. Legal Proceedings There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacities as such. 154

MANAGEMENT Officers, Directors and Director Nominees Our officers, directors and director nominees are as follows:

| Name:                |     | Age: |     | Position:                               |
| Ajmal Rahman         |     |   62 |     | Co-Chief Executive Officer and Chairman |
| Hugh Cochrane        |     |   60 |     | Co-Chief Executive Officer and Director |
| James McNaught-Davis |     |   65 |     | Head of Mergers and Acquisitions        |
| Paul Sykes           |     |   60 |     | Chief Financial Officer                 |
| William Mann         |     |   49 |     | Director Nominee                        |
| David Mikulecky      |     |   45 |     | Director Nominee                        |
| Betty Liu            |     |   52 |     | Director Nominee                        |

Upon consummation of this offering, our directors and officers will be as follows: Ajmal Rahman,62, has served as our Co -ChiefExecutive Officer and Chairman of our board of directors since June 2025. Previously, Mr. Rahman served as Chairman of Celex Oncology Innovations Ltd from July 2020 to November 2021. From December 2016 to June 2020, Mr. Rahman served as Chairman of WElink Energy Investments (U.K.) Limited, a global renewable energy and infrastructure business. Prior to that, Mr. Rahman was Chief Executive Officer and Director of Antev Ltd, a UK -basedbiotechnology company focused on urological oncology, from September 2015 to January 2020. From July 2020 to November 2021, Mr. Rahman